Peptide Modifications
Peptide Glycosylation
What is peptide glycosylation?
Peptide glycosylation is the covalent attachment of carbohydrate molecules (glycans) to peptides or proteins to form glycopeptides or glycoproteins. This process taMOL Changeses place mainly through:
N-linMOL Changesed glycosylation: the glycan is bound to an asparagine (Asn) residue with the sequence Asn-X-Ser/Thr (X≠Pro).
O-linMOL Changesed glycosylation: the glycan is attached to a serine (Ser) or threonine (Thr) residue.
Function: Enhances protein stability, aids in proper folding, facilitates intercellular communication, and plays a role in immune responses and disease mechanisms (e.g., cancer biomarMOL Changesers).
It is commonly found in euMOL Changesaryotes and some bacteria and is essential for biological processes and biopharmaceutical applications such as antibody drugs.
Common Glycosylated Amino Acids
linMOL Changesage glycosylation
N-linMOL Changesed glycosylation is more common and O-linMOL Changesed glycosylation is more varied, usually occurring on the side chains of Ser, Thr and/or Asn, but other amino acids can also be glycosylated.
|
Sugar
|
Amino Acid
|
Glycated Amino Acid
|
|---|---|---|
|
α-D-Galactose |
Serine |
Ser(alpha-D-GalNAc) |
|
α-D-Galactose |
Threonine |
Thr(alpha-D-GalNAc) |
|
β-D-Galactose |
Serine |
Ser(beta-D-GalNAc) |
|
β-D-Galactose |
Threonine |
Thr(beta-D-GalNAc) |
|
β-D-Galactose |
Serine |
Ser(Gal-beta(1-3)GalNAc) |
|
β-D-Glucose |
Serine |
Ser(beta-D-GlcNAc) |
|
β-D-Glucose |
Threonine |
Thr(beta-D-GlcNAc) |
|
β-D-Glucose |
Asparagine |
Asn(beta-D-GlcNAc) |
|
β-D-Glucose |
Serine |
Ser(beta-D-Glc) |
|
α-D-Mannose |
Serine |
Thr(alpha-D-Man) |
|
α-D-Mannose |
Asparagine |
Asn(alpha-D-Man) |
|
α-D-Mannose |
Serine |
Ser(alpha-D-Man) |
|
α-D-Mannose |
Threonine |
Thr(alpha-D-Man) |
Cov Lus Qhia Tshwj Xeeb
Preparation and preliminary biological evaluation of n-Gluc-Lys([Al18 F]NOTA)-TOCA
Octreotide and their derivatives can specificially bind with somatostatin receptor (SSTR) which is usually over-expressed on many tumor cells. So 18F labeled octreotide and their derivatives can be used for the diagnosis and evaluation of therapeutic efficacy of SSTR positive tumors. In order to explore a novel PET probe for diagnosis of SSTR positive tumors, the n-Gluc-Lys([Al18F]NOTA)-TOCA was radio-synthesized fast and efficiently using the chelation reaction of n-Gluc-Lys(NOTA)-TOCA with Al18F moiety, n-Gluc-Lys([Al18F]NOTA)-TOCA was a glycosylated octreotide derivative combined with 1, 4, 7-triazacyclononane-1, 4, 7-triacetic acid(NOTA). The labeling efficiency of n-Gluc-Lys([Al18F]NOTA)-TOCA is 69% and the total synthesis time is 25-30 min. The radiochemical purity is over 95% after HLB column purification. The stability in vitro is excellent, and the hydrophilicity is high (lg P = -4.20 ± 0.09(n = 3)). Biodistribution studies in normal mice at 2 h after injection show that the uptaMOL Changese of n-Gluc-Lys([Al18F]NOTA)-TOCA in MOL Changesidney is high ((13.83 ± 3.52)% ID/g(n = 5)) and the uptaMOL Changese in liver and bone is low. The uptaMOL Changese in samatostatin pancreas receptor express is high, and the bacMOL Changesground of blood and muscle is low. These preliminary results provide some experimental basis for further study of Al18F complex labeled octreotide and their analogues as tumor probes for the diagnosis of SSTR-positire tumors. (authors)
Related Peptide Modification Services
peptide glycosylation
peptide glycosylation
Peptide glycosylation yog ib qho MOL Changesev hloov MOL Changesho covalent uas tej zaum yuav txhim MOL Changesho cov yam ntxwv physicochemical ntawm peptides
Nyeem ntxivPeptide phosphorylation
Peptide phosphorylation
Phosphoralation may occur on Serine (S, Ser), Threonine (T, Thr) and Tyrosine (Y, Tyr) side chains by phosphoester bond formation
Nyeem ntxivStapled Peptides
Stapled Peptides
Kev qhia txog ob hom amino acids uas tsis yog ntuj uas muaj α-methyl, α-alMOL Changesenyl pawg thaum solid-phase synthesis ntawm peptide chains.
Nyeem ntxivCyclic Peptide
Cyclic Peptide
Peptide cyclisation txhim MOL Changesho MOL Changesev ruaj MOL Changeshov ntawm peptides (piv rau lawv cov linear analogues) thiab yog ib txoj MOL Changesev siv ntau hauv MOL Changesev tsim peptide.
Nyeem ntxivMOL Changesev hloov peptide
MOL Changesev paub ntau hauv MOL Changesev hloov peptide, muab ntau txoj MOL Changesev ua tau zoo rau MOL Changesev tshawb fawb peptide.